Hong Kong May Lower BioNTech Vaccine Age To 12
"); jQuery("#212 h3").html("
"); });
2021-06-02 HKT 00:38
Share this story
The Department of Health on Tuesday said it had received an application from Fosun Pharma on Saturday to lower the minimum age for the Comirnaty vaccine to 12, along with phase three clinical trial data.
It said the information had been passed on to the advisory panel on Covid-19 vaccines and that the secretary for food and health would consider any suggestions.
The department said it expected a decision could be reached quickly.
The minimum age for the Comirnaty vaccine, provided by BioNTech and its Greater China partner Fosun Pharma, is 16 in the SAR.
The minimum age for the other vaccine used in Hong Kong, which is made by Sinovac, is 18.
ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education
ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more
Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets
The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more
Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation
Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more
MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending
MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more
Why The $2 Trillion Stablecoin Prediction Is Too Low
McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more
RedotPay Eyes US IPO With Potential US$1 Billion Raise
RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more